Form 4: Fulgent Genetics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Ming Hsieh, Chief Executive Officer, a Director and 10% owner of Fulgent Genetics, Inc., reported a transaction in 4,392 shares of common stock on September 1, 2026.
Summary
- Tax/exercise-price withholding: disposed of 4,392 Common Stock at $19.59 ($86,039) on September 1, 2026; holds 885,952 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ming Hsieh — Director, Officer (Chief Executive Officer), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Tax/exercise-price withholding | Common Stock | 4,392 | $20 | $86.0K | 885,952 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Tax/exercise-price withholding (4,392 shares) |
Keywords
insider transaction, Form 4, FLGT, Fulgent Genetics, Inc., neutral, Ming Hsieh
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.